Kirin Holdings Company, Limited

Equities

2503

JP3258000003

Brewers

Market Closed - Japan Exchange 02:00:00 2024-03-28 am EDT 5-day change 1st Jan Change
2,102 JPY -0.50% Intraday chart for Kirin Holdings Company, Limited -0.73% +1.74%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Finland-based Nightingale Health to Buy Japan's Welltus MT
Nightingale Health Oyj agreed to acquire Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited. CI
B9 Beverages Private Limited announced that it has received INR 4.14086 billion in funding from Tiger Pacific Capital LP, Kirin Holdings Company, Limited CI
B9 Beverages Private Limited announced that it expects to receive INR 4.14086 billion in funding Kirin Holdings Company, Limited CI
Kirin's Profit Up 1.5% in Fiscal 2023 MT
Japan's Kirin names executive Minakata as new president RE
Japan's Kirin to name executive Takeshi Minakata as new president - Nikkei RE
Kirin sees Japan whisky 'renaissance' driving 50% export of premium brand RE
'Daigou' goes corporate as retailers seek new ways to reach Chinese shoppers RE
Japanese whisky turns 100 as craft distilleries transform industry RE
Kirin Logs Lower Nine-Month Attributable Profit Amid Increased Costs MT
L Catterton Partners completed the acquisition of Thorne HealthTech, Inc. from Mitsui & Co., Ltd., Kirin Holdings Company, Limited, Helsinn Therapeutics (U.S.), Inc., Diversified Natural Products, Inc. and others. CI
L Catterton Partners entered into a definitive agreement to acquire Thorne HealthTech, Inc. from Mitsui & Co., Ltd., Kirin Holdings Company, Limited, Helsinn Therapeutics (U.S.), Inc., Diversified Natural Products, Inc. and others for approximately $620 million. CI
Kirin Holdings’ Proceeds with Blackmore’s Acquisition for AU$1.88 Billion or 169.2 Billion Yen MT
Kirin Holdings Reports 42.2% Drop in H1 Attributable Profit; Shares Slump 6% MT
Kirin Holdings Company, Limited Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023 CI
At-home health test maker Thorne explores sale -sources RE
At-home health test maker Thorne explores sale-sources RE
Blackmores Acquisition by Kirin Holdings Takes Legal Effect MT
Nomura Adjusts Kirin's Price Target to 2,850 Yen From 2,750 Yen, Keeps at Buy MT
Kirin's Q1 Attributable Profit Drops 68% MT
Kirin Holdings Company, Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Kirin Holdings Company, Limited Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023 CI
Kirin Holdings Company, Limited Provides Dividend Guidance for the Year-End Fiscal Year Ending December 31, 2023 CI
Kirin Holdings Company, Limited Provides Dividend Guidance for the Second Quarter Fiscal Year Ending December 31, 2023 CI
Chart Kirin Holdings Company, Limited
More charts
Kirin Holdings Company, Limited is a holding company organized around 3 areas of activity: - production of beverages (61.6% of net sales): beers, wines and liqueurs (brands Budweiser, Guinness, Heineken, Franzia, Frontera, etc.), carbonated beverages (brands Kirin Lemon), fruit juices (Kirin Tropicana), mineral water (Volvic and Kirin Alkali-Ion-no-Mizu), coffees (Kirin Fire), teas (Kirin Gogo-no-kocha), dairy products etc.; - manufacturing of pharmaceutical products (19.3%): especially for anemia and allergies treatment; - other (19.1%) : mainly manufacturing of food products (seasonings, food additives, etc.). Net sales break down geographically as follows: Japan (64.1%), Oceania (9.6%), America (17.5%) and other (8.8%).
Sector
Brewers
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2,112 JPY
Average target price
2,303 JPY
Spread / Average Target
+9.03%
Consensus